Works by Zonder, Jeffrey A.

Results: 41

PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma.

Published in:

Cancers, 2022, v. 14, n. 1, p. 160, doi. 10.3390/cancers14010160

By:

Khan, Husain Yar;
Uddin, Md. Hafiz;
Balasubramanian, Suresh Kumar;
Sulaiman, Noor;
Iqbal, Marium;
Chaker, Mahmoud;
Aboukameel, Amro;
Li, Yiwei;
Senapedis, William;
Baloglu, Erkan;
Mohammad, Ramzi M.;
Zonder, Jeffrey;
Azmi, Asfar S.

Publication type:

Article

Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer.

Published in:

2006

By:

Bennett, Charles L.;
Angelotta, Cara;
Yarnold, Paul R.;
Evens, Andrew M.;
Zonder, Jeffrey A.;
Raisch, Dennis W.;
Richardson, Paul

Publication type:

Letter

Circular RNAs in acute myeloid leukemia.

Published in:

2021

By:

Singh, Vijendra;
Uddin, Mohammed Hafiz;
Zonder, Jeffrey A.;
Azmi, Asfar S.;
Balasubramanian, Suresh Kumar

Publication type:

Literature Review

Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.

Published in:

Supportive Care in Cancer, 2013, v. 21, n. 9, p. 2437, doi. 10.1007/s00520-013-1808-5

By:

Bhutani, Divaya;
Zonder, Jeffrey;
Valent, Jason;
Tageja, Nishant;
Ayash, Lois;
Deol, Abhinav;
Al-Kadhimi, Zaid;
Abrams, Judith;
Lum, Lawrence;
Ratanatharathorn, Voravit;
Uberti, Joseph;
Abidi, Muneer

Publication type:

Article

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.

Published in:

2021

By:

Mikhael, Joseph;
Belhadj-Merzoug, Karim;
Hulin, Cyrille;
Vincent, Laure;
Moreau, Philippe;
Gasparetto, Cristina;
Pour, Ludek;
Spicka, Ivan;
Vij, Ravi;
Zonder, Jeffrey;
Atanackovic, Djordje;
Gabrail, Nashat;
Martin, Thomas G.;
Perrot, Aurore;
Bensfia, Samira;
Weng, Qilong;
Brillac, Claire;
Semiond, Dorothée;
Macé, Sandrine;
Corzo, Kathryn P.

Publication type:

Letter to the Editor

Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331

By:

Dimopoulos, Meletios A.;
Migkou, Magdalini;
Bhutani, Manisha;
Ailawadhi, Sikander;
Kalff, Anna;
Walcott, Farzana L.;
Pore, Nabendu;
Brown, Miranda;
Wang, Fujun;
Cheng, Lily I.;
Kagiampakis, Ioannis;
Williams, Marna;
Kinneer, Krista;
Wu, Yuling;
Jiang, Yu;
Kubiak, Robert J.;
Zonder, Jeffrey A.;
Larsen, Jeremy;
Sirdesai, Shreerang;
Yee, Andrew J.

Publication type:

Article

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 12, p. 3320, doi. 10.3109/10428194.2015.1030641

By:

Niesvizky, Ruben;
Badros, Ashraf Z.;
Costa, Luciano J.;
Ely, Scott A.;
Singhal, Seema B.;
Stadtmauer, Edward A.;
Haideri, Nisreen A.;
Yacoub, Abdulraheem;
Hess, Georg;
Lentzsch, Suzanne;
Spicka, Ivan;
Chanan-Khan, Asher A.;
Raab, Marc S.;
Tarantolo, Stefano;
Vij, Ravi;
Zonder, Jeffrey A.;
Huang, Xiangao;
Jayabalan, David;
Di Liberto, Maurizio;
Huang, Xin

Publication type:

Article

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003

By:

Thompson, Michael A.;
Boccadoro, Mario;
Leleu, Xavier;
Vela-Ojeda, Jorge;
Rhee, Frits van;
Weisel, Katja C.;
Rifkin, Robert M.;
Usmani, Saad Z.;
Hájek, Roman;
Cook, Gordon;
Abonour, Rafat;
Armour, Mira;
Morgan, Kathryn E.;
Yeh, Su-Peng;
Costello, Caitlin L.;
Berdeja, Jesus G.;
Davies, Faith E.;
Zonder, Jeffrey A.;
Lee, Hans C.;
Omel, Jim

Publication type:

Article

P-225: A first-in-human study of FOR46 in patients with triple refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S164, doi. 10.1016/S2152-2650(21)02352-1

By:

Wong, Sandy;
Imus, Philip;
Mark, Tomer;
Kaufman, Jonathan;
Imus, Ajai;
Zonder, Jeffrey A.;
Walker, Zachary;
Sherbenou, Daniel;
Schroeder, Mark;
Abbey, Jill;
Nasoff, Marc;
Dorr, Andrew;
Liu, Bin;
Martin, Thomas

Publication type:

Article

P-064: Heterogeneity of bone marrow biopsy and bone marrow aspirate (BMA) in patients with heavily pretreated relapsed/refractory Multiple Myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S73, doi. 10.1016/S2152-2650(21)02198-4

By:

Boyapati, Anita;
Fiaschi, Nathalie;
Dhodapkar, Madhav V.;
Jagannath, Sundar;
Zonder, Jeffrey A.;
Wang, Fang;
Coetzee, Sandra;
Noguera-Troise, Irene;
Lorenc, Karen Rodriguez;
Kroog, Glenn;
Sharma, Manish

Publication type:

Article

A Randomized Phase 2 Study of Subcutaneous Daratumumab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone Alone in Patients with Multiple Myeloma who have been Previously Treated with Intravenous Daratumumab to Evaluate Retreatment (LYNX).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e246, doi. 10.1016/j.clml.2019.09.408

By:

Bahlis, Nizar J.;
Zonder, Jeffrey A.;
Wroblewski, Susan;
Qi, Ming;
Renaud, Thomas;
Jackson, Carolyn;
Facon, Thierry

Publication type:

Article

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e52, doi. 10.1016/j.clml.2019.09.080

By:

Lonial, Sagar;
Van de Donk, Niels;
Popat, Rakesh;
Zonder, Jeffrey A.;
Minnema, Monique;
Larsen, Jeremy T.;
Nguyen, Tuong Vi;
Chen, Min S.;
Bensmaine, Amine;
Peluso, Teresa;
Sonneveld, Pieter

Publication type:

Article

A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e4, doi. 10.1016/j.clml.2019.09.006

By:

Weisel, Katja;
Hungria, Vania;
Leleu, Xavier;
Lee, Hans;
Rifkin, Robert;
Costello, Caitlin;
Abonour, Rafat;
Chari, Ajai;
Puig, Noemi;
Berdeja, Jesus;
Cook, Gordon;
Thompson, Michael A.;
Boccadoro, Mario;
Terpos, Evangelos;
Zonder, Jeffrey A.;
Vela-Ojeda, Jorge;
Davies, Faith;
van Rhee, Frits;
Hajek, Roman;
Spencer, Andrew

Publication type:

Article

HORIZON (OP-106) Study of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S329, doi. 10.1016/j.clml.2019.07.318

By:

Richardson, Paul G.;
Oriol, Albert;
Larocca, Alessandra;
Otero, Paula Rodriguez;
Norkin, Maxim;
Bladé, Joan;
Cavo, Michele;
Hassoun, Hani;
Leleu, Xavier;
Alegre, Adrián;
Maisel, Christopher;
Paner, Agne;
Mazumder, Amitabha;
Zonder, Jeffrey A.;
Puig, Noemí;
Harran, John;
Harmenberg, Johan;
Thuresson, Sara;
Zubair, Hanan;
Mateos, Maria-Victoria

Publication type:

Article

A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146

By:

Costello, Caitlin;
Boccadoro, Mario;
Usmani, Saad Z.;
Chari, Ajai;
Rifkin, Robert M.;
Abonour, Rafat;
Berdeja, Jesus;
Cook, Gordon;
Goldschmidt, Hartmut;
Hajek, Roman;
Hungria, Vania;
Lee, Hans C.;
Leleu, Xavier;
Omel, Jim;
Spencer, Andrew;
Thompson, Michael A.;
Vela-Ojeda, Jorge;
Zonder, Jeffrey A.;
Puig, Noemi;
Aguarón, Alfonso

Publication type:

Article

Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Response.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e97, doi. 10.1016/j.clml.2017.03.175

By:

Gertz, Morie A.;
Comenzo, Raymond L.;
Landau, Heather;
Sanchorawala, Vaishali;
Weiss, Brendan M.;
Zonder, Jeffrey A.;
Walling, Jackie;
Kinney, Gene G.;
Koller, Martin;
Schenk, Dale B.;
Guthrie, Spencer D.;
Liu, Enchi;
Liedtke, Michaela

Publication type:

Article

NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From a Phase 1/2 Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e22, doi. 10.1016/j.clml.2017.03.038

By:

Gertz, Morie A.;
Comenzo, Raymond L.;
Landau, Heather;
Sanchorawala, Vaishali;
Weiss, Brendan M.;
Zonder, Jeffrey A.;
Walling, Jackie;
Kinney, Gene G.;
Koller, Martin;
Schenk, Dale B.;
Guthrie, Spencer D.;
Liu, Enchi;
Liedtke, Michaela

Publication type:

Article

Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e79, doi. 10.1016/j.clml.2017.03.144

By:

Rifkin, Robert;
Davies, Faith;
Palumbo, Antonio;
Zonder, Jeffrey A.;
Girnius, Saulius;
Costello, Caitlin;
Usmani, Saad;
Berdeja, Jesus;
Omel, Jim;
Thompson, Michael;
Schwartz, J Sanford;
Hajek, Roman;
Terpos, Evangelos;
Hungria, Vania;
Mateos, Maria-Victoria;
Cook, Gordon;
Leleu, Xavier;
Spencer, Andrew;
Goldschmidt, Hartmut;
Seal, Brian

Publication type:

Article

Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study.

Published in:

2016

By:

Berdeja, Jesus;
Jagannath, Sundar;
Zonder, Jeffrey;
Badros, Ashraf;
Kaufman, Jonathan L.;
Manges, Robert;
Gupta, Manish;
Tendolkar, Amol;
Lynch, Mark;
Bleickardt, Eric;
Paliwal, Prashni;
Vij, Ravi

Publication type:

journal article

Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.

Published in:

Patient Preference & Adherence, 2022, v. 16, p. 573, doi. 10.2147/PPA.S345906

By:

Auclair, Daniel;
Mansfield, Carol;
Fiala, Mark A;
Chari, Ajai;
Cole, Craig E;
Kaufman, Jonathan L;
Orloff, Gregory J;
Siegel, David S;
Zonder, Jeffrey A;
Mange, Brennan;
Yesil, Jennifer;
Dalal, Mehul;
Mikhael, Joseph R

Publication type:

Article

A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.

Published in:

2017

By:

Shah, Jatin J.;
Kaufman, Jonathan L.;
Zonder, Jeffrey A.;
Cohen, Adam D.;
Bensinger, William I.;
Hilder, Brandi W.;
Rush, Selena A.;
Walker, Duncan H.;
Tunquist, Brian J.;
Litwiler, Kevin S.;
Ptaszynski, Mieke;
Orlowski, Robert Z.;
Lonial, Sagar

Publication type:

journal article

A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.

Published in:

2016

By:

Chari, Ajai;
Htut, Myo;
Zonder, Jeffrey A.;
Fay, Joseph W.;
Jakubowiak, Andrzej J.;
Levy, Joan B.;
Lau, Kenneth;
Burt, Steven M.;
Tunquist, Brian J.;
Hilder, Brandi W.;
Rush, Selena A.;
Walker, Duncan H.;
Ptaszynski, Mieke;
Kaufman, Jonathan L.

Publication type:

journal article

A phase II trial of BAY 43-9006 (sorafenib) ( NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.

Published in:

Cancer Medicine, 2014, v. 3, n. 5, p. 1275, doi. 10.1002/cam4.276

By:

Srkalovic, Gordan;
Hussein, Mohamad A.;
Hoering, Antje;
Zonder, Jeffrey A.;
Popplewell, Leslie L.;
Trivedi, Harsha;
Mazzoni, Sandy;
Sexton, Rachel;
Orlowski, Robert Z.;
Barlogie, Bart

Publication type:

Article

A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 564, doi. 10.1111/ejh.13937

By:

Derman, Benjamin A;
Chari, Ajai;
Zonder, Jeffrey;
Major, Ajay;
Stefka, Andrew T;
Jiang, Ken;
Karrison, Theodore;
Jasielec, Jagoda;
Jakubowiak, Andrzej

Publication type:

Article

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.

Published in:

Annals of Hematology, 2021, v. 100, n. 9, p. 2325, doi. 10.1007/s00277-021-04534-8

By:

Davies, Faith;
Rifkin, Robert;
Costello, Caitlin;
Morgan, Gareth;
Usmani, Saad;
Abonour, Rafat;
Palumbo, Antonio;
Romanus, Dorothy;
Hajek, Roman;
Terpos, Evangelos;
Cherepanov, Dasha;
Stull, Dawn Marie;
Huang, Hui;
Leleu, Xavier;
Berdeja, Jesus;
Lee, Hans C.;
Weisel, Katja;
Thompson, Michael;
Boccadoro, Mario;
Zonder, Jeffrey

Publication type:

Article

Myonecrosis in Sickle Cell Anemia--Overlooked and Underdiagnosed.

Published in:

2010

By:

Tageja, Nishant;
Racovan, Marius;
Valent, Jason;
Zonder, Jeffrey

Publication type:

Case Study

Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited.

Published in:

Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/801495

By:

Jay Yang;
Terebelo, Howard R.;
Zonder, Jeffrey A.

Publication type:

Article

The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.

Published in:

Expert Opinion on Drug Discovery, 2017, v. 12, n. 2, p. 225, doi. 10.1080/17460441.2017.1268596

By:

Arkwright, Richard;
Pham, Tri Minh;
Zonder, Jeffrey A.;
Dou, Q. Ping

Publication type:

Article

Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.

Published in:

Current Hematologic Malignancy Reports, 2006, v. 1, n. 3, p. 141, doi. 10.1007/s11899-996-0002-y

By:

Zonder, Jeffrey;
Schiffer, Charles

Publication type:

Article

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.

Published in:

British Journal of Haematology, 2019, v. 186, n. 4, p. 549, doi. 10.1111/bjh.15969

By:

Jakubowiak, Andrzej J.;
Jasielec, Jagoda K.;
Rosenbaum, Cara A.;
Cole, Craig E.;
Chari, Ajai;
Mikhael, Joseph;
Nam, Jennifer;
McIver, Amanda;
Severson, Erica;
Stephens, Leonor A.;
Tinari, Kathryn;
Rosebeck, Shaun;
Zimmerman, Todd M.;
Hycner, Tyler;
Turowski, Agata;
Karrison, Theodore;
Zonder, Jeffrey A.

Publication type:

Article

Daratumumab proves safe and highly effective in AL amyloidosis.

Published in:

British Journal of Haematology, 2019, v. 185, n. 2, p. 342, doi. 10.1111/bjh.15455

By:

Khouri, Jack;
Kin, Andrew;
Thapa, Bicky;
Reu, Frederic J.;
Bumma, Naresh;
Samaras, Christy J.;
Liu, Hien D.;
Karam, Mary A.;
Reed, Janice;
Mathur, Saveta;
Faiman, Beth M.;
Devries, Georgia;
Zonder, Jeffrey;
Valent, Jason

Publication type:

Article

The difficult business of assessing new therapies for smouldering multiple myeloma.

Published in:

2018

By:

Zonder, Jeffrey A.

Publication type:

Editorial

A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma ( NPI-0052-107): final study results.

Published in:

British Journal of Haematology, 2018, v. 180, n. 1, p. 41, doi. 10.1111/bjh.14987

By:

Spencer, Andrew;
Harrison, Simon;
Zonder, Jeffrey;
Badros, Ashraf;
Laubach, Jacob;
Bergin, Krystal;
Khot, Amit;
Zimmerman, Todd;
Chauhan, Dharminder;
Levin, Nancy;
MacLaren, Ann;
Reich, Steven D.;
Trikha, Mohit;
Richardson, Paul

Publication type:

Article

Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.

Published in:

Amyloid, 2023, v. 30, n. 2, p. 161, doi. 10.1080/13506129.2022.2137400

By:

Dispenzieri, Angela;
Zonder, Jeffrey;
Hoffman, James;
Wong, Sandra W.;
Liedtke, Michaela;
Abonour, Rafat;
D'Souza, Anita;
Lee, Charlene;
Cote, Sarah;
Potluri, Ravi;
Ammann, Eric;
Tran, NamPhuong;
Lam, Annette;
Nair, Sandhya

Publication type:

Article

Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.

Published in:

2019

By:

Lentzsch, Suzanne;
Lagos, Galina G.;
Comenzo, Raymond L.;
Zonder, Jeffrey A.;
Pregja, Silva;
Osman, Keren;
Tsai, Wei-Yann;
Landau, Heather;
Sanchorawala, Vaishali

Publication type:

Letter

Chronic lymphocytic leukemia presenting in association with aplastic anemia.

Published in:

American Journal of Hematology, 2002, v. 71, n. 4, p. 323, doi. 10.1002/ajh.10226

By:

Zonder, Jeffrey A.;
Keating, Michael;
Schiffer, Charles A.

Publication type:

Article

Precursor T Cell Acute Lymphoblastic Lymphoma Presenting as Bilateral Facial Nerve Palsy.

Published in:

Chemotherapy (0009-3157), 2010, v. 56, n. 3, p. 258, doi. 10.1159/000316847

By:

Tageja, Nishant;
Valent, Jason;
Bentley, Gail;
Zonder, Jeffrey

Publication type:

Article

Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 358, doi. 10.1002/cam4.4451

By:

Pan, Darren;
Kaufman, Jonathan L.;
Htut, Myo;
Agrawal, Manish;
Mazumder, Amitabha;
Cornell, Robert F.;
Zonder, Jeffrey A.;
Fay, Joseph W.;
Modiano, Manuel R.;
Moshier, Erin L.;
Rush, Selena A.;
Tunquist, Brian J.;
Chari, Ajai

Publication type:

Article

Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma.

Published in:

Blood & Lymphatic Cancer: Targets & Therapy, 2017, p. 53, doi. 10.2147/BLCTT.S82444

By:

Bhutani, Divaya;
Zonder, Jeffrey A.

Publication type:

Article

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function.

Published in:

Cancer (0008543X), 2010, v. 116, n. 16, p. 3807, doi. 10.1002/cncr.25139

By:

Dimopoulos, Meletios;
Alegre, Adrian;
Stadtmauer, Edward A.;
Goldschmidt, Hartmut;
Zonder, Jeffrey A.;
de Castro, Carlos M.;
Masliak, Zvenyslava;
Reece, Donna;
Olesnyckyj, Marta;
Yu, Zhinuan;
Weber, Donna M.

Publication type:

Article

Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma.

Published in:

Oncology & Therapy, 2016, v. 4, n. 2, p. 287, doi. 10.1007/s40487-016-0034-y

By:

Baz, Rachid;
Zonder, Jeffrey;
Gasparetto, Cristina;
Reu, Frederic;
Strout, Vincent

Publication type:

Article